We report here the subsequent identification of STRN gene as the ALK fusion partner and the screening via RT-PCR of a series of 75 thyroid carcinoma samples in order to test the presence of the STRN/ALK fusion. This evidence concerns the gene STRN and thyroid gland carcinoma.